BIODESIX INC
NASDAQ: BDSX (Biodesix, Inc.)
Last update: 8 hours ago8.53
-11.31 (-57.01%)
| Previous Close | 19.84 |
| Volume | 1,581,376 |
| Price / Sales | 1.85 |
| Price / Book | 24.72 |
| 52 Weeks Range |
| Profit Margin | -54.28% |
| Operating Margin (TTM) | -50.47% |
| Diluted EPS (TTM) | -0.270 |
| Quarterly Revenue Growth (YOY) | 21.20% |
| Total Debt/Equity (MRQ) | 577.44% |
| Current Ratio (MRQ) | 2.22 |
| Operating Cash Flow (TTM) | -41.94 M |
| Levered Free Cash Flow (TTM) | -31.89 M |
| Return on Assets (TTM) | -23.33% |
| Return on Equity (TTM) | -1,454.41% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Mixed | Bullish |
| Diagnostics & Research (Global) | Mixed | Bullish | |
| Stock | Biodesix, Inc. | Mixed | Mixed |
AIStockmoo Score
| Value 40% | -2.9 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | -2.9 |
| Timing 40% | -0.3 |
| AI Technical info | NA |
| Technical Oscillators info | -0.5 |
| Technical Moving Averages info | 0.0 |
| Smart Money 20% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | NA |
| Environment | ×1.13 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | NA |
| Pillar Agreement | ×1.25 |
| Not in score | |
| Price Volatility info | 0.9 |
| Final Score | -1.81 |
Select this tab to load the latest available analysis.
|
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Small Value |
| % Held by Insiders | 52.11% |
| % Held by Institutions | 36.46% |
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |